Search bioRxiv⌕ Search

Biology subjects

CHERRADI, N.

Publications and source records attributed to CHERRADI, N..

2 recordsLinked to original sources

Benchmarking microRNA Target Prediction Algorithms Using Single-Cell Co-Sequencing Data

(1) BackgroundMicroRNAs (miRNAs) are small non-coding RNAs that play pivotal roles in the post-transcriptional regulation of gene expression, influencing a wide range of physiological and pathological processes. Accurately identifying miRNA targets is crucial for understanding miRNA modes of action. To this aim, a plethora of algorithms have been developed to predict miRNA targets, each employing distinct methodologies and relying on different features. The limited overlap among target predictions generated by various algorithms underscores the necessity for comprehensive and independent benchmarks to evaluate their performance. (2) MethodsWe selected seven algorithms among the most popular ones to perform a benchmark with an original approach using recently published datasets of miRNA-mRNA co-sequencing at the single-cell level. We used Gene Set Enrichment Analysis to assess algorithms capabilities to predict sets of targets statistically anti-correlated in expression with miRNAs. We worked with both co-sequencing datasets of human and mouse single-cells. (3) ResultsOur benchmark shows high performances for mirDIP, which corresponds to the consensus result of 24 different algorithms, for human miRNAs. In human cell lines, Diana microT, TargetScan, miRmap, and miRDB also provide excellent results, while RNA22 and miRWalk exhibited poorer results. In mouse primary cells, Diana microT leads, closely followed by miRmap. Intriguingly, RNA22 performs better in mouse primary cells than in human cell lines. Moreover, our benchmark highlights the benefit of reducing targets to the experimentally validated ones. Finally, we demonstrated that performance varies depending on the number of targets used, with TargetScan performing better than mirDIP when considering only a few dozen targets.

bioinformatics↗

Aberrant activation of Wnt/β-Catenin signaling pathway drives the expression of poorprognosis-associated microRNAs in adrenocortical cancer with a major impacton miR-139-5p and its host gene PDE2A

Adrenocortical carcinoma (ACC) is a rare malignancy with dismal prognosis. Deregulated microRNA (miRNA) expression has been implicated in ACC aggressiveness. Nevertheless, the mechanisms underlying such deregulations remain unknown. Aberrant Wnt/{beta}-Catenin signaling has been reported in about 40% of ACC and is associated with poor outcome. Here, we investigated the link between constitutive activation of Wnt/{beta}-Catenin pathway and miRNA expression alterations in ACC. Inducible shRNA-mediated gene silencing of {beta}-Catenin ({beta}-Cat) was performed in ACC cells expressing constitutively active {beta}-Catenin. The miRnome of ACC cells was analyzed using RNA-Sequencing. Selected miRNAs and mRNAs were validated using quantitative PCR and functional experiments with an emphasis on miR-139-5p, its host gene phosphodiesterase 2A (PDE2A) and its target gene N-Myc Downstream-Regulated Gene 4 (NDRG4). Prognostic values of Wnt/{beta}-Catenin pathway components or mutational status and their correlations with miRNA/mRNA expressions were determined in COMETE-ENSAT and TCGA cohorts. We carried out the first miRnome analysis in {beta}-Catenin-deficient ({beta}-Cat-) ACC cells. Twelve upregulated miRNAs and 42 downregulated miRNAs among which miR-139-5p and miRNAs of the 14q32 locus were identified in {beta}-Cat- cells. Downregulation of selected poor prognosis-associated miRNAs was confirmed using RT-qPCR. Remarkably, the expression of the intronic miR-139-5p was decreased by 90% in {beta}-Cat- cells with a concomitant repression of its host gene PDE2A and upregulation of its target gene NDRG4. In ACC patients, miR-139-5p levels were highly correlated with the levels of PDE2A and anti-correlated with those of NDRG4. MiR-139-5p and PDE2A expressions were higher in patients with mutations in components of Wnt/{beta}-Catenin signaling pathway or high expression of LEF1, with LEF1 proving a better predictor of prognosis than Wnt/{beta}-Catenin signaling pathway mutational status. Our findings indicate that in addition to inducing protein-coding genes in ACC, constitutively active Wnt/{beta}-Catenin signaling upregulates the expression of a subset of miRNAs involved in tumour aggressiveness and poor clinical outcome.

cancer biology↗